Alfredo Sandoval

Alfredo Sandoval

Auto-generated profile, based on publicly available information

Alfredo Sandoval

Department of Neurobiology, University of Texas Medical Branch, Galveston, TX 77555, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
QLQiang Li
Qiang Li
ASAlfredo Sandoval
Alfredo Sandoval
JMJohn Moth
John Moth
JSJunkui Shang
Junkui Shang
JLJia Yi Liew
Jia Yi Liew
BCBo Chen
Bo Chen
Spinal cord injury (SCI) results in acute damage and triggers secondary injury responses with sustained neuronal loss and dysfunction. However, the underlying mechanisms for these delayed neuronal pathologies are not entirely understood. SCI results in the swelling of spinal neurons, but the contribution of cell swelling to neuronal loss and functional deficits after SCI has not been systematically characterized. In this study, we devised a three-dimensional image analysis pipeline to evaluate spinal neurons, examining their types, quantities, volumes, and spatial distribution in a double-lateral hemisection SCI mouse model. We found that both excitatory and inhibitory neurons swell and are lost, albeit with distinct temporal patterns. Inhibitory neurons demonstrated marked swelling and decline in number on day 2 after SCI, which resolved by day 14. In contrast, excitatory neurons maintained persistent swelling and continued cell loss for at least 35 days after SCI in mice. Excitatory neurons exhibited sustained expression of the Na + -K + -Cl − cotransporter 1 (NKCC1), whereas inhibitory neurons down-regulated the protein by day 14 after SCI. Treatment with a Food and Drug Administration–approved NKCC1 inhibitor, bumetanide, mitigated swelling of excitatory neurons and reduced their loss in the secondary injury phase after SCI. The administration of bumetanide after SCI in mouse improved locomotor recovery, with functional benefits persisting for at least 4 weeks after treatment cessation. This study advances our understanding of SCI-related pathology and introduces bumetanide as a potential treatment to mitigate sustained neuronal swelling and enhance recovery after SCI.

25 February 2020 in eneuro
Verified
Journal Article
Open access
PDF file
ASAlfredo Sandoval
Alfredo Sandoval
HEHajira Elahi
Hajira Elahi
JPJonathan E. Ploski
Jonathan E. Ploski
The multitude of neuronal subtypes and extensive interconnectivity of the mammalian brain presents a substantial challenge to those seeking to decipher its functions. While the molecular mechanisms of several neuronal functions remain poorly characterized, advances in next-generation sequencing (NGS) and gene-editing technology have begun to close this gap. The clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein (CRISPR-Cas) system has emerged as a powerful genetic tool capable of manipulating the genome of essentially any organism and cell type. This technology has advanced our understanding of complex neurologic diseases by enabling the rapid generation of novel, disease-relevantin vitroand transgenic animal models. In this review, we discuss recent developments in the rapidly accelerating field of CRISPR-mediated genome engineering. We begin with an overview of the canonical function of the CRISPR platform, followed by a functional review of its many adaptations, with an emphasis on its applications for genetic interrogation of the normal and diseased nervous system. Additionally, we discuss limitations of the CRISPR editing system and suggest how future modifications to existing platforms may advance our understanding of the brain.

20 April 2023 in Neural Regeneration Research
Verified
Journal Article
Open access
QLQiang Li
Qiang Li
AJAlfredo Sandoval Jr
Alfredo Sandoval Jr
BCBo Chen
Bo Chen

10 November 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JSJoseph Sandoval
Joseph Sandoval
ASAlfredo Sandoval
Alfredo Sandoval
ASArsalan Saleem
Arsalan Saleem
Background: Differences among radiomics implementations complicate cross-study comparisons, while voxel-wise feature extraction remains computationally demanding. We developed MLX-Radiomics to accelerate regional feature extraction and voxel-wise mapping while preserving agreement with standardized reference measurements. Methods: MLX-Radiomics implements 172 feature definitions from the Image Biomarker Standardization Initiative (IBSI), 16 extensions and the IBSI 2 image filters. We assessed agreement with IBSI reference data and evaluated numerical accuracy against independent double-precision and analytic calculations. In matched comparisons on Apple M1 Max and M5 Max systems, we used the IBSI reference CT to compare feature values, extraction time and memory use with PyRadiomics, MIRP and Flash-Radiomics, and feature values with FastRad. Separately, we compared the time required to generate voxel-wise feature maps for regions of up to 10.1 million voxels with published GPU results obtained on different hardware and images. We evaluated agreement with MIRP under published settings in a 51-patient cohort with CT, FDG PET and T1-weighted MRI. Results: MLX-Radiomics agreed with all 2,160 IBSI reference measurements within the specified tolerances. With matching outputs, MLX-Radiomics was 2.66 to 7.27 times faster than PyRadiomics and MIRP for regional feature extraction and 198 to 218 times faster than PyRadiomics for voxel-wise mapping on a 24 3 -voxel crop. It also outperformed the fastest Flash-Radiomics CPU configurations tested. On the M5 Max, generating 93 maps over 10.1 million voxels took 23.8 s. In the patient cohort, MLX-Radiomics and MIRP agreed on 98.0% of requested values. For tumors at the image edge, matching the libraries’ resampling rules substantially improved agreement. Conclusions: MLX-Radiomics provides standardized regional measurements and voxel-wise maps for CT, PET and MRI, with evidence of faster extraction limited to CT. It can support quantitative imaging research on relatively inexpensive hardware without requiring a separate GPU workstation.

29 October 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JSJoseph Sandoval
Joseph Sandoval
ASAlfredo Sandoval
Alfredo Sandoval
ASArsalan Saleem
Arsalan Saleem
Background: Medical imaging research increasingly combines specialized artificial intelligence models for segmentation, detection, image synthesis and report generation. For three-dimensional CT and MRI, these workflows typically run on NVIDIA GPUs with substantial memory. On-device AI on widely available Apple Silicon computers could broaden access to these models for clinical researchers. These computers share a large memory pool between the CPU and GPU, which suits workflows that combine several models. However, few established imaging models run natively on Apple Silicon. Adapting a model to new hardware also requires verifying that its results match the original software. Methods: We developed MedMLX, a collection of 21 established medical imaging models rewritten for Apple Silicon in MLX, Apple’s machine learning framework. The collection includes nnU-Net, TotalSegmentator, MedSAM2 and SAM 3. The models segment organs and tumors, detect lung nodules, generate synthetic images and draft radiology reports from CT, MRI, PET/CT, radiographs and endoscopic images. Using public cases from 11 imaging datasets, we compared the models’ results with those of the original software run on an Intel CPU and an NVIDIA GPU. Agreement required a Dice coefficient of at least 0.99 for every segmentation label and equivalent criteria for other outputs. We measured memory use and processing time on an Apple M1 Max computer with 64 GB of memory. Results: MedMLX agreed with the original software in 211 of 212 comparisons. The single exception was a brain MRI segmentation. On this case, the original software itself gave different results on the two devices. We illustrated sequential workflows, including anatomical segmentation of a synthetic brain MRI and lesion synthesis guided by organ segmentation. With a memory-saving setting, 19 of the 21 models used less than 16 GB of memory. This setting reduced memory use by a median of 49% and increased processing time by a median of 13%. Conclusions: MedMLX enables on-device AI with established medical imaging models on Apple Silicon computers rather than specialized NVIDIA hardware. The models agree closely with the original software, and most need less than 16 GB of memory.